Publication Month - 2020 | Mar | Mar | Mar | Apr | Mar | Apr | Mar | Apr | Apr | Mar | May | May | May | Apr |
Country | China | China | China | China | China | France | China | China | Italy | China | China | Italy | USA | USA |
No. Patients ≥60 Years Old | 339 | 114 | 136 | 55 | 18 | 17 | 7 | 6 | 961 | 4 | 105 | 31 | 117 | 2582 |
Age | >60 | >70 | ≥60 | ≥65 | ≥60 | >67 | >61 | >75 | ≥61 | 64-71 | ≥ 60 | ≥65 | ≥65 | >65 |
Male | 166 | 67 | 58 | 34 | 12 | 8 | 4 | 2 | 783 | 2 | 48 | 19 | - | - |
Symptoms No. | Table 1 | Table 1 | Table 1 | Table 1 | Table 1 | Table 1 | Table 1 | Table 1 | Table 1 | Table 2 | Table 1 | Table 1 | Table 1 | - |
Comorbidities No. | - |
Outcome No. | 676 Discharged 1487 (613 ICU) Hospitalized 419 Death |
Hospital Stay duration (days) - Median (IQR) | Discharged: 4.5 (2.7 - 7.2) Still hospitalized: 4.4 (2.3-8.0) Dead: 4.4 (2.1 - 7.1) |
Complications*(%) | Most common complications of patients ≥60 years old | | |
| (42) SI | - | (17) ARDS | - | (39) HI | (59) RI | (100) Pn | (33) SI | - | - | (10) ARDS | (35) ARDS | - | (30) RI |
| (29) HI | - | (10) RI | - | (39) RI | (47) HI | (86) ARDS | - | - | - | (5) AHI | (29) SI | - | - |
| (21) ARDS | - | (10) HI | - | (22) SI | - | (43) RF | - | - | - | (5) RI | (10) Sh | - | - |
| (21) AHI | - | | - | (22) ARDS | - | (29) RI | - | - | - | (1) HI | (1) AHI | - | - |
| (17) CI | - | - | - | (17) AHI | - | (29) HI | - | - | - | - | - | - | - |
Others | (8) RI | - | - | - | | - | (29) SI (14) CI (14) Sh | - | - | - | - | - | - | - |
≤5 % | Sh | | Sh | | Sh | | | | | | | | | HI |
Treatment** (%) | | |
| - | (97) AvT | (86) AvT | (62) Ster | (89) LR | - | (100) Rv | (100) AvT | - | (75) LR | (93) AvT | (68) AbT | - | - |
| - | (85) AbT | (50) IFN | (27) IFN | (67) AbT | - | (100) IFN | (100) AbT | - | (75) Ig | (60) AbT | (61) LR | - | - |
| - | (45) Ig | (31) Um | (18) LR | (33) IFN | - | (57) Ig | (50) Ster | - | (50) Um | (49) Ster | (55) Ster | - | - |
| - | - | (18) Ig | (13) Um | (22) Ig | - | (57) Os | (33) Ig | - | (50) Cef | (43) Ig | - | - | - |
| - | - | (9) LR | (9) Ig | | - | (43) Ster | | - | (50) Moxi | - | - | - | - |
| - | - | - | - | - | - | - | - | - | (25) Os | - | - | - | - |
| - | - | - | - | - | - | - | - | - | (25) IFN | - | - | - | - |
| - | - | - | | - | - | - | | - | (25) Lin | - | - | - | - |
Supplementary Oxygen No. (%) | - | 104 (91) | - | 49 (89) | 17 (95) | 8 (47) | - | 6 (100) | 615 (64) | - | 89 (85) | 28 (90) | 104 (89) | - |
Mechanical Ventilation (MV) ° No. (%) | - | - | - | 24 (44) | - | - | 6 (86) | - | - | - | - | - | - | - |
Invasive MV | - | - | 6 (5) | - | 4 (22) | - | 3 (43) | 0 | 709 (74) | - | 8 (8) | 8 (26) | 48 (41) | 558 (22) |
Non-Invasive MV | - | - | 3 (2) | - | 1 (6) | - | - | 3 (50) | 80 (8) | - | 7 (7) | - | 5 (4) | - |
Other Treatments°° (%) | - | (70) TCM (50) HT (28) VD (3) Hem | - | (55) MA (9) ThyF | (78) ThyP (78) TCM (11) RRT (6) ECMO | - | - | - | - | (75) ThyF (75) Chlor (75) S | (64) NCa (3) ECMO | (77) HyC (74) Hep (13) Toc | (82) NCa (11) RRT (43) VS (7) CPR | (4) RRT |